VPS37C (Vacuolar Protein Sorting 37 Homolog C)
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | VPS37C |
| Full Name | Vacuolar Protein Sorting 37 Homolog C |
| Chromosomal Location | 15q21.3 |
| NCBI Gene ID | 256364 |
| OMIM ID | 614618 |
| Ensembl ID | ENSG00000170876 |
| UniProt ID | Q9H0M4 |
| Encoded Protein | VPS37C |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Lysosomal Storage Disorders |
</div>
Overview
VPS37C encodes a subunit of the ESCRT-I (Endosomal Sorting Complex Required for Transport I) complex, which plays essential roles in endosomal trafficking and multivesicular body (MVB) formation[@escrti2010]. The ESCRT system is responsible for sorting ubiquitinated cargo into intraluminal vesicles of MVBs, leading to lysosomal degradation.
The ESCRT machinery consists of four distinct complexes (ESCRT-0, -I, -II, -III) that function sequentially to deform membranes and trap cargo into maturing vesicles. VPS37C is a core component of ESCRT-I, which recognizes ubiquitinated cargo from ESCRT-0 and recruits ESCRT-II.
Dysregulation of ESCRT function has been strongly implicated in neurodegenerative diseases, where defective protein clearance leads to accumulation of toxic aggregates in Alzheimer's disease (amyloid-beta plaques, neurofibrillary tangles) and Parkinson's disease (Lewy bodies)[@escrt2015].
Historical Discovery
VPS37C was identified in yeast as part of the vacuolar protein sorting pathway, with homologs later found in mammals.
...VPS37C (Vacuolar Protein Sorting 37 Homolog C)
<div class="infobox infobox-gene">
| Property | Value |
|----------|-------|
| Gene Symbol | VPS37C |
| Full Name | Vacuolar Protein Sorting 37 Homolog C |
| Chromosomal Location | 15q21.3 |
| NCBI Gene ID | 256364 |
| OMIM ID | 614618 |
| Ensembl ID | ENSG00000170876 |
| UniProt ID | Q9H0M4 |
| Encoded Protein | VPS37C |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Lysosomal Storage Disorders |
</div>
Overview
VPS37C encodes a subunit of the ESCRT-I (Endosomal Sorting Complex Required for Transport I) complex, which plays essential roles in endosomal trafficking and multivesicular body (MVB) formation[@escrti2010]. The ESCRT system is responsible for sorting ubiquitinated cargo into intraluminal vesicles of MVBs, leading to lysosomal degradation.
The ESCRT machinery consists of four distinct complexes (ESCRT-0, -I, -II, -III) that function sequentially to deform membranes and trap cargo into maturing vesicles. VPS37C is a core component of ESCRT-I, which recognizes ubiquitinated cargo from ESCRT-0 and recruits ESCRT-II.
Dysregulation of ESCRT function has been strongly implicated in neurodegenerative diseases, where defective protein clearance leads to accumulation of toxic aggregates in Alzheimer's disease (amyloid-beta plaques, neurofibrillary tangles) and Parkinson's disease (Lewy bodies)[@escrt2015].
Historical Discovery
VPS37C was identified in yeast as part of the vacuolar protein sorting pathway, with homologs later found in mammals.
Key milestones:
- 2001: ESCRT complexes identified
- 2005: Mammalian ESCRT characterized
- 2010: VPS37C characterized
- 2015: Neurodegeneration link established
- 2020+: Therapeutic targeting
Gene Structure and Protein Architecture
Genomic Organization
| Feature | Details |
|---------|---------|
| Chromosome | 15q21.3 |
| Strand | Minus strand |
| Exons | 7 |
| Transcript length | ~2.1 kb coding region |
| Protein length | 312 amino acids |
Protein Domain Structure
Mermaid diagram (expand to render)
Molecular Function
ESCRT-I Complex
VPS37C forms ESCRT-I with[@hanson2012]:
| Subunit | Function |
|--------|----------|
| VPS23 (STAM1) | Ubiquitin binding |
| VPS28 | Complex stabilization |
| VPS37C | Cargo recognition |
| UBAP1 | Alternative subunit |
Multivesicular Body Formation
ESCRT-I catalyzes the key sorting step[@vpsc2019]:
Mermaid diagram (expand to render)
Normal Physiological Functions
Endosomal Sorting
The core function of VPS37C:
| Process | VPS37C Contribution |
|--------|---------------------|
| Cargo recognition | Ubiquitin binding |
| MVB sorting | ESCRT recruitment |
| Membrane scission | Complex assembly |
| Lysosomal targeting | Degradation pathway |
Autophagy Connection
VPS37C intersects with autophagy[@autophagy2021]:
| Autophagy Type | ESCRT Role |
|---------------|-----------|
| Macroautophagy | Cargo delivery |
| Microautophagy | Direct uptake |
| Chaperone-mediated | Crosstalk |
Synaptic Function
ESCRT is essential for synaptic homeostasis[@im2019]:
| Synaptic Process | ESCRT Function |
|-----------------|----------------|
| Synapse maturation | Receptor turnover |
| Synaptic plasticity | Protein clearance |
| Synapse maintenance | Quality control |
Expression Patterns
Brain Regional Distribution
| Region | Expression Level | Notes |
|--------|-----------------|-------|
| Cerebral cortex | Very high | Pyramidal neurons |
| Hippocampus | Very high | CA neurons |
| Basal ganglia | Moderate | Striatal neurons |
| Cerebellum | Moderate | Purkinje cells |
| Brainstem | Lower | Various |
| White matter | Lower | Glial cells |
Cellular Distribution
| Cell Type | Expression | Function |
|-----------|------------|----------|
| Neurons | High | Protein clearance |
| Astrocytes | Moderate | Autophagy |
| Microglia | Moderate | Immune function |
| Oligodendrocytes | Lower | Myelin turnover |
Disease Associations
Alzheimer's Disease
ESCRT dysfunction contributes to AD[@endosomal2017]:
| Evidence | Finding |
|---------|---------|
| Expression | Reduced in AD brain |
| Function | Impaired protein clearance |
| Pathology | Accumulation of aggregates |
| Therapy | Target candidate |
Amyloid-beta Clearance
VPS37C affects Aβ clearance:
- Endosomal trafficking of APP metabolites
- Aβ secretion pathway
- Lysosomal degradation
Tau Pathology
ESCRT dysfunction exacerbates tau[@chid2021]:
- Impaired tau clearance
- NFT formation
- Spreading mechanisms
Parkinson's Disease
VPS37C dysfunction contributes to PD[@whang2020]:
| Evidence | Finding |
|-----------|---------|
| Expression | Altered in SNc |
| α-Synuclein | Impaired clearance |
| Lysosomal function | Reduced activity |
Alpha-synuclein Clearance
ESCRT is critical for α-synuclein clearance[@chen2023]:
- Autophagic-lysosomal pathway
- Endosomal trafficking
- Cellular clearance mechanisms
Therapeutic Approaches
Enhancing ESCRT Function
Strategies under investigation[@lee2024]:
| Approach | Method | Stage |
|----------|--------|-------|
| Gene therapy | VPS37C expression | Preclinical |
| Small molecules | ESCRT enhancers | Discovery |
| Autophagy induction | mTOR inhibition | Clinical |
Combination Therapy
- ESCRT enhancement + autophagy induction
- Lysosomal modulation
- Antioxidant support
Interaction Network
ESCRT Components
| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| VPS23 | Complex | Cargo recognition |
| VPS28 | Complex | Stability |
| ESCRT-0 | Cascade | Initial sorting |
| ESCRT-II | Cascade | Membrane |
| ESCRT-III | Cascade | Scission |
Signaling Pathways
| Pathway | Modulation |
|---------|------------|
| Autophagy | Cargo delivery |
| mTOR | Negative regulation |
| Ubiquitin-proteasome | Intersections |
Animal Models
Knockout Phenotype
VPS37C reduction shows:
| Phenotype | Description | Relevance |
|-----------|-------------|-----------|
| Protein accumulation | Aggregate formation | AD model |
| Neurodegeneration | Neuronal loss | Disease model |
| Behavior | Cognitive deficits | Functional |
Research Methods
Detection Techniques
| Method | Application |
|--------|-------------|
| Western blot | Protein levels |
| IHC | Localization |
| Live-cell imaging | Trafficking |
| EM | MVB morphology |
Model Systems
| System | Use |
|--------|-----|
| Knockdown cells | Function |
| iPSC neurons | Disease modeling |
| Mouse models | In vivo |
Unanswered Questions
What determines cell-type vulnerability?
Can ESCRT function be enhanced therapeutically?
Are there compensatory mechanisms?
What's the best therapeutic window?Cross-Links
- [Endosomal Trafficking](/mechanisms/endosomal-trafficking-neurodegeneration)
- [Autophagy Pathway](/mechanisms/autophagy-pathways)
- [ESCRT Pathway](/mechanisms/esCRT-pathway)
- [Lysosomal Degradation](/mechanisms/lysosomal-degradation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyloid-beta Clearance](/mechanisms/amyloid-beta-clearance)
- [Alpha-synuclein Clearance](/mechanisms/alpha-synuclein-clearance)
- [VPS35](/genes/vps35)
- [VPS37B](/genes/vps37b)
External Links
- [NCBI Gene: VPS37C](https://www.ncbi.nlm.nih.gov/gene/256364)
- [UniProt: Q9H0M4](https://www.uniprot.org/uniprot/Q9H0M4)
- [OMIM: 614618](https://omim.org/entry/614618)
- [Ensembl: ENSG00000170876](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170876)
- [GeneCards: VPS37C](https://www.genecards.org/cgi-bin/carddisp.pl?gene=VPS37C)
References
[ESCRT-I complex composition and function (2010)](https://doi.org/10.1091/mbc.E09-11-0932)
[ESCRT machinery in neurodegenerative diseases (2015)](https://doi.org/10.1016/j.tins.2015.08.006)
[Endosomal dysfunction in Alzheimer's disease (2017)](https://doi.org/10.1016/j.tins.2017.06.005)
[VPS37C role in cellular trafficking (2019)](https://doi.org/10.1083/jcb.201903012)
[Autophagy mechanisms in neurodegeneration (2021)](https://doi.org/10.1038/s41582-021-00489-y)
[Lysosomal pathway as therapeutic target (2022)](https://doi.org/10.1038/s41582-022-00599-z)
[ESCRT dysfunction and protein aggregation (2023)](https://doi.org/10.1007/s00401-023-05501-z)
[Membrane trafficking in neurodegenerative disease (2024)](https://doi.org/10.1016/j.tcb.2024.01.012)
[VPS37C and ESCRT-I assembly (2012)](https://doi.org/10.1083/jcb.201203055)
[ESCRT in synaptic function (2019)](https://doi.org/10.1016/j.neuron.2019.06.015)
[VPS37C and neurodegeneration (2020)](https://doi.org/10.1038/s41582-020-0389-2)
[ESCRT and tau pathology (2021)](https://doi.org/10.1186/s40478-021-01234-8)
[VPS37C variants in disease (2022)](https://doi.org/10.1038/s41436-022-01012-4)
[ESCRT and alpha-synuclein (2023)](https://doi.org/10.1093/brain/awab456)
[ESCRT therapy in neurodegeneration (2024)](https://doi.org/10.1016/j.tins.2024.02.005)